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The Matrix protein M1 from 
influenza C virus induces tubular 
membrane invaginations in an  
in vitro cell membrane model
David Saletti1,2,*, Jens Radzimanowski3,*, Gregory Effantin3, Daniel Midtvedt4, 
Stéphanie Mangenot1,2, Winfried Weissenhorn3, Patricia Bassereau1,2 & Marta Bally1,2,4
Matrix proteins from enveloped viruses play an important role in budding and stabilizing virus particles. 
In order to assess the role of the matrix protein M1 from influenza C virus (M1-C) in plasma membrane 
deformation, we have combined structural and in vitro reconstitution experiments with model 
membranes. We present the crystal structure of the N-terminal domain of M1-C and show by Small 
Angle X-Ray Scattering analysis that full-length M1-C folds into an elongated structure that associates 
laterally into ring-like or filamentous polymers. Using negatively charged giant unilamellar vesicles 
(GUVs), we demonstrate that M1-C full-length binds to and induces inward budding of membrane 
tubules with diameters that resemble the diameter of viruses. Membrane tubule formation requires 
the C-terminal domain of M1-C, corroborating its essential role for M1-C polymerization. Our results 
indicate that M1-C assembly on membranes constitutes the driving force for budding and suggest that 
M1-C plays a key role in facilitating viral egress.
Enveloped viruses exit the host cell via budding, where newly assembled virions become progressively wrapped 
by the membrane of the infected cells, before pinching off the cell surface by membrane fission. This process can 
be nucleated at the inner leaflet of the plasma membrane and requires the bending of the membrane into vesicles 
or “buds” deformed away from the protein-binding leaflet and exhibiting therefore a strong negative curvature1.
Influenza virus, member of the negative strand segmented RNA virus orthomyxoviridae family, is an example 
of a virus exiting his host by budding from the plasma membrane2. Influenza viruses are classified into the genera 
Influenza A, B and C where Influenza A and B are major pathogens3,4. Although influenza C is less widespread, 
it causes respiratory infections in young children4 and mild upper respiratory infections in adults, possibly due 
to the presence of protective antibodies acquired early in life5. All influenza viruses are pleomorphic, assuming 
either a spheroidal morphology with a diameter of ~100 nm or forming filaments with a length up to several 
micrometers and a diameter of ~100 nm2,6. Generally, laboratory-adapted strains of influenza virus A form mostly 
spherical particles and clinical isolates are often filamentous7,8. The membrane of influenza viruses contains the 
glycoproteins hemagglutinin (HA), neuraminidase (NA), the ion channel M2 while the M1 matrix protein forms 
a coat associated with the inner leaflet of the viral membrane. Viruses enter cells by endocytosis and exposure to 
the endosomal pH is required for membrane fusion leading to the delivery of the ribonucleoproteins (RNP) into 
the cytoplasm. For their egress, prior to virus budding, assembly of glycoproteins, RNPs and the matrix protein 
M1 is initiated at the plasma membrane in case of influenza A virus2. Upon completion of assembly, influenza A 
virus release depends on the action of M29 in an ESCRT (Endosomal sorting Complex required for Transport) 
–independent process10,11.
Matrix proteins from negative strand RNA viruses constitute the major structural protein and are the driving 
force for budding2,12–14. However, influenza A M1 (M1-A) lacks a membrane targeting sequence and is recruited 
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to the plasma membrane by HA and/or NA through interactions with their cytoplasmic tails15,16 or by the M2 
protein17. Accordingly, heterologous M1 expression in eukaryotic cells does not lead to virus-like particle (VLP) 
formation although M1-VLP release was reported upon influenza A virus M1 expression with vaccinia virus 
and baculoviruses expression systems18,19. Nevertheless, fusion of a N-terminal membrane targeting sequence 
to M1 from influenza A virus can lead to VLP formation17 suggesting that M1 is sufficient for VLP formation 
once targeted to membranes. Due to the lack of efficient membrane targeting by influenza A virus M1 alone, 
co-expression of HA, NA, M2 and M120 or of either HA or NA together with M1 and M221 is otherwise required 
for release of VLPs. Furthermore, expression of HA or NA alone also leads to spherical20 and filamentous VLPs, 
respectively21. However, in the context of infectious virions, the spherical or filamentous morphology depends 
on M1 in the case of influenza A and C viruses6,22–25. M1 from influenza C virus (M1-C) has been shown to be 
the key component in inducing the formation of protrusions, called cord-like structures (CLS), emanating out of 
infected cells26 and in regulating their growth23,27 thus demonstrating a role for M1-C in membrane remodeling.
M1 from influenza A virus is composed of an N-terminal helical domain28–31 which carries positive charges 
implicated in membrane binding in vitro32. In addition, positively charged residues of M1-A (R76/77/78) are 
required for M1 membrane targeting and attachment as well as incorporation into virions33,34. However, the basic 
surface may not suffice for membrane interaction in vivo35. The N-terminal domain is followed by a short linker 
that was proposed to contain a zinc binding site36 and the C-terminal domain. The latter dimerizes in vitro37, is 
essential for M1 polymerization38 and provides a link to the ribonucleoprotein (RNP)32. Full-length M1 from 
influenza virus A forms an elongated structure39 containing a compact N-terminal domain and an extended 
and partially flexible C-terminal domain under low pH conditions40. Influenza virus A M1 polymerization is 
enhanced upon membrane binding41 and cryoelectron microscopy analyses suggest that M1 forms a helical pol-
ymer underneath the viral membrane42. Finally, during influenza A virus entry, M1 release from the viral mem-
brane is induced by the low pH in endosomes in a two-step mechanism43, which may lead to structural changes 
in M1 before release44,45.
In the context of understanding cell-membrane-related processes and membrane biophysics, cell membrane 
mimics have attracted considerable interest46–49. Giant unilamellar vesicles (bilayers in the form of spherical ves-
icles with a diameter ranging from 10 to 100 μ m, GUV50) in particular, are well-suited to investigate membrane 
deformation processes induced by colloids51, polymers52,53, viral proteins54, or toxins55 but also to probe mem-
brane fission9,56.
Here, we combine structural studies and GUV-based experiments to understand the M1-C induced mem-
brane deformation. We show that the N-terminal domain of M1-C adopts a similar fold as M1-A, despite the low 
sequence homology of both proteins, but coordinates two Mg2+ ions which increases the positive surface charge 
and may thus facilitate electrostatic interactions with negatively charged membranes. Full length M1-C adopts 
an elongated structure that tends to polymerize into ring-like or filamentous structures via lateral interactions of 
M1-C protomers. M1-C interaction with GUVs containing negatively charged lipids leads to inward membrane 
tubulation, topologically similar to virus budding. Although the N-terminal domain on its own interacts with 
GUVs, tubulation requires the C-terminal domain. Our study thus confirms that M1-C assembly on membranes 
constitutes the driving force for influenza C virus bud formation.
Results
Structure of M1-C. We expressed and purified full-length M1-C (Ann Arbor/1/1950), which produces mon-
omeric M1-C as determined by size exclusion chromatography (SEC) and small angle x-ray scattering (SAXS) 
measurements (Table 1). In addition to the fraction of M1-C eluting as a monomer from the SEC column, ring-
like and/or spiral structures were present in the void volume fraction of the SEC column at low pH conditions. 
The filaments have a width of approximately 12.5 + /− 2.5 nm and ring diameters of approximately 50–100 nm 
(Fig. 1a). M1-C SAXS analysis (Fig. 1b) revealed a radius of gyration (Rg) of 2.85 nm and maximal dimensions of 
11 nm in a low pH (pH 5.7) buffer. Although M1-C is also soluble at physiological pH, the SAXS data could not be 
analyzed due to a slight tendency to form higher order oligomers. M1-C (Ann Arbor/1/1950) and M1-A (Puerto 
Rico/8/1934 H1N1) share 14.29% sequence similarity (see Supplementary Fig. S1) and comparison of the SAXS 
data obtained at low pH suggests that they adopt similar structures. M1-A produces an Rg of 3 nm and maximal 
dimensions of 11 nm (Table 1) similar to previous analyses39,40. The molecular weight (MW) of the solute obtained 
from the extrapolated I(0) value was 27 kDa (27.9 kDa, calculated MW) for M1-A and 23 kDa for M1-C (26.9 kDa, 
calculated MW) confirming the monomeric state of M1 at low pH. The Kratky plots of M1-C and M1-A are bell-
shaped, typical for folded proteins. At higher angles, elevated scattering is observed which indicates that part of 
the protein may be flexible (Fig. 1c). Ab initio modeling of M1-C produced an elongated 10 nm long structure 
fitting the corresponding experimental data with a discrepancy χ value of 0.916 (Fig. 1d) similar to the model 
calculated for M1-A40.
We solved the crystal structure of C-terminally truncated M1-C, (NTD, residues 1–155) by single anomalous 
dispersion (SAD) techniques to a resolution of 1.5 Å (Table 2). The structure is composed of a tandem repeat of 
two four-helical bundles (helices 1–4 and 6–9) that are connected by a long linker containing helix 5 (Fig. 2a). 
Interactions between the two four helical bundles and with the linker are hydrophobic as in the case of M1-A 
structures28,29,31,39. The overall fold is similar to known M1-A NTD crystal structures28,29,31,39, albeit their low 
sequence homology (see Supplementary Fig. S1). Superposition of the Cα atoms with M1-A (pdb 1EA3) reveals 
an overall r.m.s.d. of 2.86 Å. Major changes are observed for the position of helix 6, which moves approximately 
10 Å outwards (Fig. 2c). A notable difference between the M1-A and M1-C structures is the unexpected coor-
dination of 2 Mg2+ ions by helix 5 residues. The first Mg2+ ion is coordinated by Asn80, Asp130, Glu126 and 
three water molecules and the second Mg2+ ion interacts with Thr83, Glu123, Glu126 and three water molecules 
(Fig. 2b). Nevertheless the presence of Mg2+ may not have a structural role since circular dichroism showed no 
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difference in melting temperature (TM = 62 °C) in the presence or absence of EDTA (ethylenediaminetetraacetic 
acid). However, the presence of the two Mg2+ ions changes the electrostatic potential of the M1-C surface. In 
the absence of Mg2+ this surface is substantially less positively charged (Fig. 3a, panel 1), while in the presence 
of Mg2+, the basic charge distribution is similar to that of M1-A (Fig. 3a, panel 1, and b). The other M1 surfaces 
carry a similar charge distribution, although the surface opposite to the basic surface (Fig. 3a,b; panels 3) is less 
negatively charged in the case of M1-C. It is thus very likely that M1-C employs also one of its basic surfaces to 
interact with negatively charged phospholipids present in the plasma membrane to initiate budding as suggested 
for M1-A28,29,31,39,57.
M1-C binds to GUVs containing negatively charged lipids and induces inward tubulations. The 
interaction between M1-C and lipid membranes was investigated using GUVs of two different lipid compositions. 
The first composition contained 33 mol% of the negatively charged lipid DOPS, in addition to DOPE (33 mol%) 
and DOPC (33 mol%) (herein referred to as DOPS-GUV). The second composition consisted of lipids extracted 
from a natural tissue (porcine brain extract), which contains approximately 10 wt% PS lipids, to which 5 mol% 
Rg (nm) I0 sRg max (nm) Dmax (nm)
MW from 
I0 (kDa)
MW from 
volume (kDa)
Scattering 
power Vc Qr Mass (kDa)
M1-A 3.0 25.5 0.6–1.2 11 27 30 8.0 3.1 3.2 26
M1-C 2.85 24.8 0.6–1.2 11 23 26 8.3 3.0 3.1 25
Table 1.  Summary of SAXS analyses for M1 from influenza virus C (M1-C) and influenza virus A (M1-A).
Figure 1. Structural analysis of M1-C. (a) M1-C forms polymers in vitro at low pH conditions as shown by 
negative staining electron microscopy. The width of the circular or spiral filaments is approximately 10 nm. The 
inset shows a close-up of some rod-like structures that associate laterally to form the filament. The scale bars are 
50 nm. (b) M1-C also forms monomers at low pH conditions that produced the experimental SAXS data (red); 
the scattering pattern computed from the Dammin model shown in d is drawn in green. (c) Kratky plots for 
M1-C (red) and M1-A (blue). (d) Structural model of M1-C produced at low pH and reconstructed ab initio.
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PI(4,5)P2 was added (herein referred to as TBE-GUVs). Therefore, in this study, we worked with two extreme 
cases: a very simple composition, i.e. a “minimal model of the cell membrane” consisting of a protein-binding 
lipid and background non-interacting lipids and a more complex, native-like membrane, possibly reflecting the 
properties of native membranes more closely.
After growing the GUVs by electroformation, proteins were added outside the GUVs at different bulk concen-
trations and fluorescence images were acquired at the equatorial plane of the vesicle. As visible in Fig. 4a M1-C 
interacted with vesicles of both compositions. The negatively charged lipids were a prerequisite for binding, as 
suggested by control experiments performed using vesicles containing DOPC only (DOPC-GUV). This observa-
tion is in good agreement with previous reports on M1-A58 further confirming that electrostatics play a key role 
in mediating membrane interactions for the M1 of both genera. Furthermore, this is in line with the general idea 
that both proteins exhibit a similar structure-function relationship. Interestingly, the interaction was shown to 
induce tubular membrane invaginations visible both in the protein (green) and lipid (red) channel (Fig. 4a). All 
protrusions were oriented towards the inside of the GUV thus topologically mimicking virus budding. Tubules 
were not observed in control samples without proteins (data not shown). These observations indicate that the 
protein alone is capable of negative curvature generation without the contribution of any other viral or cellular 
proteins. For both charged compositions, the tubules had diameters below the resolution of the microscope. 
Nevertheless, we could estimate from the relative intensities of bodipy-ceramide at the equator of the GUVs 
and in the tubules59 (see materials and methods for details) that the average tubule diameters range between 
approximately 120 and 250 nm; tubules generally appeared to be narrower at higher protein bulk concentrations 
M1-C (see Supplementary Fig. S2). The tubules were up to several micrometers long, appeared to be rather stiff 
and formed at M1-C concentrations above 3 μ M for DOPS-GUVs and above 300 nM for TBE-GUVs. Tubulation 
was more common for the TBE-GUVs with > 50% of the vesicles showing tubulation for protein concentrations 
in the low μ M range (Fig. 4b). For the same concentration window, only approximately 10% of the DOPS-GUVs 
exhibited tubulation and the fraction of vesicles with tubules never exceeded 60% for all concentrations tested 
(Fig. 4b,c), in spite of the fact that DOPS-GUVs appeared to bind more M1-C, as shown by the evaluation of the 
mean intensity of the vesicle at the rim (Fig. 4d and Supplementary Fig. S3). We conclude that negative charges 
are required for M1-C membrane interaction and that membrane tubules budding into the GUV interior is more 
favorable for TBE-GUVs. To further investigate the possible relation between protein density and the tubulation 
process, the number of tubules on each vesicle was counted and normalized to the circumference of the vesicle 
equator, yielding the tubule density. As shown in Fig. 4d, the TBE-GUVs and DOPS-GUVs exhibited a clearly 
distinct tubulation behavior with higher tubule densities achieved at lower protein density for TBE-GUVs, indi-
cating that less protein is required to deform the TBE-GUV membrane as compared to the DOPS-GUVs. For 
M1-C SAD
Data collection
 Space group C121
Cell dimensions
 a, b, c (Å) 66.398 26.841 77.224
Α , β , γ (°) 90.00 108.40 90.00
Wavelength 0.9791
Resolution (Å) 31.5–1.5 (1.58–1.5)
Rsym 0.063 (0.527)
I/σ I 12.1 (2.4)
Completeness (%) 99.3 (99.3)
Multiplicity 3.7 (3.8)
Refinement
 Resolution (Å) 1.5
 No. Reflections Test set reflections 20868 1074
 Rwork/Rfree 18.8/21.9
No. atoms
 Protein 1235
 Ligand/ion 2 Mg2+
 Water 186
B-factors
 Protein 26.4
 Ligand/ion 30
 Water 36.1
R.m.s deviations
 Bond lengths (Å) 0.006
 Bond angles (°) 0.969
Table 2. Crystallographic data collection and refinement statistics.
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each individual composition, the dependence of the number of tubules per vesicle with the protein density was 
not very pronounced, although a weak linear trend can be found.
M1-C clusters at the surface of the GUVs. To gain more detailed insights into the assembly of the M1 
protein layer on the lipid membranes, z-stacks were acquired by spinning disc confocal microscopy yielding a 
three-dimensional image of the GUVs. To visualize protein binding on the surface more easily, the stacks were 
projected into one plane, effectively portraying the vesicles either from below or above as shown in Fig. 5. In 
both cases, the M1 protein was found to cluster on the surface of the GUVs. For both vesicle types, binding 
appeared to be more homogeneous at high bulk protein concentrations, while the clusters became more promi-
nent as the concentration was decreased. (For a quantitative analysis of cluster density see Supplementary Fig. S4) 
Interestingly, the cluster morphology was very distinct for both lipid compositions investigated. As visible in 
Fig. 5a, for TBE-GUVs, M1-C assembled into connected network-like structures. The projected representation 
used in Fig. 5 has the disadvantage that it becomes difficult to differentiate between structures on the surface of 
the GUV and tubules inside the vesicle, as tubules perpendicular to the imaging plane, for example, will appear 
as intense spots. However, careful inspection of the images revealed that the majority of the network structures 
Figure 2. Structure of the M1-C N-terminal domain. (a) Ribbon diagram of M1-C composed of two four-
helical bundles connected by helix 5. Alpha helices are labeled. (b) Close up of the Mg2+ binding sites. M1-C 
binds two Mg2+ ions coordinated by residues from helices 5 and 8 and six water molecules. Alpha helices 
are labeled. (c) Superposing of the Cα atoms of M1-A and M1-C reveals an overall similar fold and the 
displacement of helix 6.
www.nature.com/scientificreports/
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visible in these projections were found at the GUV surface, as further illustrated in Fig. 6c and visualized in the 
Supplementary Movie. Such a network structure was never observed for the DOPS-GUVs; as visible in Fig. 5b, 
the protein rather assembles into more compact and round clusters.
To gain further insights into the process leading to protein clustering and tubulation, experiments were 
performed using low concentrations of fluorescently-labeled PI(4,5)P2 or fluorescently-labeled ceramide. 
Representative projections shown in Fig. 6a clearly display a colocalization of the fluorescent lipids (red) and flu-
orescent M1-C (green) indicating that both PIP(4,5)P2 and bodipy-ceramide are enriched at sites of M1-C inter-
action. This is further confirmed by estimating the Pearson correlation coefficient of our images and performing 
the statistical test described in ref. 60. We find that the colocalization lies above the confidence level of 3-times the 
standard deviation in all conditions (see Supplementary Table T1, for values and details). The observation of colo-
calization on bodipy-ceramide, a lipid that does not interact with M1-C (as shown in Fig. 4aiii) suggests that this 
Figure 3. Electrostatic potential map comparison of M1-C and M1-A. M1 has large basic surfaces. 
Electrostatic potential map of M1-C (a) compared to the M1-A map (b). The electrostatic potential was 
calculated from − 3.000 KbT/ec (red) to + 3.000 KbT/ec (blue).
www.nature.com/scientificreports/
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enrichment originates, at least in part, from local membrane deformations at the vesicle surface. Indeed, the fluo-
rescence increase reflects the surface projection of the curved membrane, thus a purely geometrical effect. Further 
analysis of the ratio of the lipid signal under the M1-C protein clusters and around them reveals that this effect 
dominates over local recruitment of PIP(4,5)P2 since the ratios are similar in both experiments with fluorescent 
labeled lipids (ratios: 1.75 ± 0.42 and 1,79 ± 0,32 for fluorescent PIP(4,5)P2 and for the fluorescent ceramide, 
respectively). These ratios further indicate that the deformation corresponds to less than half-cylinder with a 
diameter below optical resolution, since in this case the fluorescence would be locally increased by a factor π .
The N-terminal domain is not sufficient to induce membrane tubulations. To obtain fur-
ther insight into M1-C function, experiments were performed using only the N-terminal domain of M1-C 
(M1C-NTD). M1C-NTD interacts with negatively charged membranes (Fig. 7), in agreement with the proposal 
that M1 NTD from M1-A contains the membrane binding region32,39. However, the N-terminal domain alone 
does not induce membrane deformation or tubulation (Fig. 7) and no protein clustering is observed, in contrast 
with full length M1-C. This strongly indicates that the C-terminal domain is required for M1-C polymerization 
possibly stabilizing interactions between protomers. Although M1 matrix protein assembly might drive mem-
brane deformation, we cannot exclude the possibility that membrane deformation itself affects M1 assembly at 
the membrane.
Discussion
The exact molecular mechanisms underlying influenza virus budding and the role of M1 polymerization in 
budding are still elusive. Here, we applied structural biology and a minimal membrane model system based on 
GUVs to elucidate the role of M1-C in membrane deformation and budding. We find that the structure of the 
N-terminal domain of M1-C resembles the structure of that of M1-A despite a low sequence similarity28,29,31,39. 
Figure 4. M1-induced tubulations. (a) Representative confocal images at the vesicles equator of (i) TBE-
GUVs, (ii) DOPS-GUVs and (ii) DOPC-GUVs after incubation with M1. The red signal corresponds to bodipy-
ceramide lipids incorporated into the GUV membrane and the green signal to Alexa-488 M1-C. Protein-
induced membrane tubules are visible for the negatively charged vesicles of both compositions. No binding 
is observed in absence of negatively charged lipids. The protein concentration was 1.9 μ M for the TBE-GUV 
experiment and 2.8 μ M for the DOPS-GUVs and the DOPC-GUVs. Scale bars: 10 μ m. The fraction of vesicles 
with tubulation in independent experiments for (b) TBE-GUVs and (c) DOPS-GUVs as a function of protein 
bulk concentration. (d) Tubule density at the equator as a function of the average intensity of the vesicle rim 
for TBE-GUVs (crosses) and DOPS-GUVs (circles) together with their respective linear fits (dotted line: TBE-
GUVs; full line: DOPS-GUVs). Each data point corresponds to one analyzed vesicle and only vesicles with at 
least one tubule at the equator were taken into account.
www.nature.com/scientificreports/
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In addition, M1-C coordinates two Mg2+ ions, which are not present in the M1-A structure. Although Mg2+ 
coordination does not seem to have a structural role, its presence greatly enhances the positive charge of helices 
5 and 8 on the N-terminal domain. Notably, the corresponding basic surface of M1-A was implicated in binding 
to negatively charged bilayers28,29,31,32,39, although electrostatic interactions may not constitute the sole driving 
force for membrane targeting35. In particular, helix 6 has a number of basic residues in M1-A and M1-C and 
mutations within helix 6 of M1-A affect membrane interaction57 as well as virus morphology61. This is consistent 
with the finding that membrane binding enhances M1 oligomerization and thus polymerization41 indicating 
that both membrane interaction and polymerization are concomitant processes. We also confirm that full length 
M1-C forms an elongated structure at low pH with an extended possibly flexible C-terminal domain, as predicted 
for M1-A by SAXS analysis39,40. We show that the C-terminal domain is required for M1-C polymerization into 
ring-like or filamentous structures in vitro, consistent with the role of conserved C-terminal residues in M1-A 
oligomerization38,62. Because we show that the M1C-NTD alone binds to GUVs but does not induce membrane 
tubule formation in our experiments with GUVs, we conclude that M1-C polymerization on membranes requires 
the C-terminal domain and generates M1 assemblies that are capable to reshape membranes. Because in vivo 
imaging of M1-A polymers in native virions indicates the presence of a helical matrix layer42, a similar M1-C 
layer is expected to form during M1-C membrane tubule formation on GUVs. Furthermore, imaging of M1-A 
after release from virion membranes revealed spiral structures with a filament width of approximately 10 nm58. 
The width of these spiral filamentous structures is similar to the width of the M1-C polymers described here. 
Because the length of the M1-A and M1-C monomer structures is approximately 11 nm based on SAXS analyses, 
we suggests that elongated M1 structures line up via lateral interactions between neighboring N-terminal and 
C-terminal domains such as they expose the basic surface required for membrane interaction on the outside of 
the ring or spiral structures. We hypothesize that the negative curvature, inherent to the M1-C filaments, bends 
membranes upon filament growth into a helical M1 polymer42.
Our study on a model membrane system demonstrates that M1-C alone is capable of deforming a lipid mem-
brane into tubular protrusions with negative curvature. The M1-C generated tubules are relatively stiff and up to 
several micrometers long. This morphology is reminiscent of that of filamentous Influenza C virions, but in con-
trast with the in vivo situation, M1-C-induced membrane tubules grow in vitro without restriction in the absence 
of the RNPs and/or the glycoproteins HA, NA and the M2 protein that is required for scission9 and thus restricts 
tubule length. Interestingly, the in vitro tubules exhibit diameters of the order of approximately 100–250 nm at high 
M1-C density, which resembles the diameter of influenza virions. Membrane deformation by viral matrix proteins 
has been shown so far for the vesicular stomatitis virus matrix protein that generates large (>1 μ m) spherical buds 
that stay attached to the GUV membrane54. In addition, Ebola virus and New Castle disease virus matrix proteins 
also induce budding and release large (>1 μ m) spherical vesicles from GUVs63,56. Because of the large size of the 
released vesicles, the physiological relevance may be limited. In contrast, our M1-C-induced membrane tubules 
Figure 5. M1-C clustering at the GUV surface. Fluorescence projections of the protein signal on (a) TBE-
GUVs and (b) DOPS-GUVs vesicles. For TBE-GUVs, proteins assemble into a network-like structure on the 
vesicle surface. For DOPS-GUVs the protein forms clusters but does not assemble into networks. A quantitative 
estimate of the number of clusters and network density can be found in Supplementary Fig. S4 (c) Z-stack 
images of a TBE-GUV vesicle incubated with 345 nM M1-C taken at the bottom (glass side) at the equator and 
at the top of the GUV. Scale bars: 10 μ m.
www.nature.com/scientificreports/
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are much smaller in diameter. Because the structure of the polymer is likely crucial to define the bud size, it is 
interesting to note that the M1-C helical or ring-like filaments imaged in vitro in solution by electron micros-
copy resemble the diameter of infectious virions. Furthermore, M1-C cluster formation upon binding to the lipid 
membrane is in agreement with the observation that M1-A also assembles elongated clusters with a network-like 
morphology or round-shaped clusters on supported lipid bilayers depending on the lipid composition41, although 
supported bilayers that prevent membrane deformation may not be ideal to study M1 polymerization.
In the case of TBE-GUVs, the presence of a network structure is correlated with tubulation. Linear assemblies 
and networks with very small mesh size (of the order of tens of nanometers) preceding membrane tubulation 
have been predicted by numerical simulations for proteins with an anisotropic shape, such as BAR domain pro-
teins64–66, thus for systems where protein-protein interactions were absent, i.e. very different from the M1-C 
case. Currently, to the best of our knowledge, no simulation or experimental data on network assembly has been 
reported for polymerizing proteins such as M1-C. Therefore, it remains to be elucidated whether the network-like 
morphology represents a precursor state in the tubulation process or whether an alternative dead-end polymeri-
zation state, not relevant for the tubulation process. Furthermore, although it is likely that protein clustering and 
tubulation are related processes, as further suggested by the results with M1-NTD where no clustering or tubula-
tion is observed, it is important to note that there is no direct correlation between size and amount of clusters and 
the amount of tubules on the GUVs.
We further show that the lipid composition affects M1-C membrane tubule formation. Tubulation was 
observed for the DOPS-GUVs, although much less pronounced than for the TBE-GUV mixture, where tubules 
were nucleated at lower M1 surface densities as compared to the DOPS-GUV system. This observed difference 
might have a number of origins related to the physical properties of the membrane (e.g. bending rigidity, spon-
taneous curvature, membrane tension or overall charge) or to the nature of the interaction with the negatively 
charged lipids. In the context of this work, membrane rigidity can be excluded as a likely cause for the differ-
ence in tubulation behavior observed for the two membrane compositions. Indeed, the bending rigidity for 
the DOPS-GUV was found to be approximately four times lower than the bending rigidity of the TBE-GUVs 
(12 ± 4KBT59 vs 46 ± 4.5KBT67) indicating that from a membrane-mechanics perspective, membrane defor-
mation should be more favorable for the DOPS-GUVs (see for instance ref. 68). Another factor which may 
have a major influence on tubulation onset is the presence of lipids with an intrinsic negative curvature, such 
as Phosphatidylethanolamine (PE)-lipids68. Although DOPS-GUVs contain 33% DOPE while the TBE-GUVs 
contain only ~17% of PE-lipids, it is important to mention that about 60% of the TBE lipid composition is not 
known, thus it is possible that other lipids than PE with a negative curvature are present in this lipid mixture and 
contribute to facilitate tubulation.
Another hypothesis is that PI(4,5)P2 lipids amplify membrane tubulation. Although they do not increase M1 
binding to the membrane, they may induce an arrangement of the proteins more favorable for M1-C polymer-
ization and thus membrane tubulation. We therefore propose that the presence of PI(4,5)P2 in the bilayer may 
Figure 6. Colocalization experiment using labeled lipids. (a) Projections of TBE-GUVs with a negatively 
charged fluorescently-labeled lipid (Bodipy TMR PI(4,5)P2). The red signal corresponds to Bodipy TMR 
PI(4,5)P2 incorporated to the GUV membrane and the green signal to Alexa-488 M1-C. The negatively 
charged fluorescent lipids co-localize with the protein network. Scale bar: 10 μ m. (b) (i) Projections of TBE-
GUVs containing small amounts of bodipy-ceramide, a lipid that does not interact with M1 C. The red signal 
corresponds to bodipy-ceramide lipids incorporated to the GUV membrane and the green signal to Alexa-488 
M1-C. In both cases, the protein bulk concentration was 1.4 μ M. (ii) Control experiment using vesicles without 
fluorescent lipids at maximum laser power: only signal noise is detected, showing the absence of bleed-through 
between the fluorescence channels. Scale bar: 10 μ m.
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increase M1-C filament assembly required for budding. A detailed investigation on the influence of different 
membrane components on the tubulation process will be the subject of future investigations.
The egress mechanism of Influenza has attracted particular attention after the recognition that the virus does 
not depend on the ESCRT machinery to pinch-off the plasma membrane10,69, but is catalyzed instead by the M2 
ion channel protein as demonstrated in vitro9. Our model system of M1-C induced membrane tubules that stay 
connected to the outer GUV membrane provides an excellent system to study influenza virus scission under more 
quasi physiological conditions to test hypotheses such as to the role of lipid domain formation70,71 or of the plasma 
membrane lipid composition72.
Materials and Methods
Reagents. Porcine brain total lipid extract (TBE), 1,2-dioleoyl-sn-glycero-3-phospho-(1′ -myo-inositol-4′ ,5′ 
-bisphosphate) (PI(4,5)P2), 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-dioleoyl-snglycero-3-phos-
phoethanolamine (DOPE) and 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS) were purchased from 
avanti lipids. Fluorescent BODIPY-Texas Red Ceramide (bodipy-ceramide) was from molecular probes and the 
BODIPY-TMR-PI(4,5)P2 from Tebu-bio. All other chemicals were purchased from Sigma-Aldrich.
Protein expression and purification. The M1 protein of Influenza (strain C/Ann Arbor/1/1950) was 
cloned into a pET21d vector using the NdeI and XhoI restriction sites. Expression was performed in BL21 RIL 
(DE3) cells for 18 h at 20 °C. Cells were lysed by sonication in lysis buffer containing 150 mM NaCl, 50 mM Tris 
pH 7.5 and 1 μ g ml−1 lysozyme. The cell lysate was centrifuged at 20 000 g and 277 K. The pellet fraction contain-
ing the protein in inclusion bodies (IBs) was washed five times in lysis buffer without lysozyme but with 2.0% 
(v/v) TritonX-100 and then twice in lysis buffer without detergent.
The purified IBs were solubilized in 6 M guanidinium hydrochloride (GdnHCl) and then diluted with water 
to a final concentration of 4 M GdnHCl. Refolding of M1-C was performed by the rapid dilution method with 
100 mM NaCl, 100 mM Tris pH 8.0 and 0.8 M l-arginine as the refolding buffer. The refolded protein was further 
dialyzed in 20 mM MES pH 5.7, 10 mM NaCl and loaded onto a heparin column. The protein was eluted by apply-
ing a salt gradient between 10 mM and 1 M NaCl. Fractions containing M1-C were concentrated and further puri-
fied on a S75 (100/300) size exclusion chromatography column equilibrated in 10 mM MES pH 5.7, 100 mM NaCl.
Electron microscopy analysis. For negative staining, M1-C was adsorbed to the clean side of a carbon film 
on mica, stained with 1% sodium silicotungstate pH 7.0, attached to a 400-mesh copper grid and transferred into 
a JEOL1200 EX II operating at 100 kV. The images were taken on a 2.7 k by 2.7 k Gatan ORIUS CCD camera at a 
nominal magnification of x20000.
Crystallization, data collection and structure determination. M1-C NTD was crystallized in 
100 mM Tris pH8.0, 200 mM MgCl2 and 25% PEG3350 by mixing 1 μ l of the reservoir to 1 μ l of protein at 15 mg/ml. 
The crystals were cryoprotected in the same conditions but with addition of 20% glycerol and flash cooled in liq-
uid N2 before data collection. Se-Met derivatized crystals of M1-C NTD grew under the same conditions. A data 
set from a Se-Met crystal was collected at a wavelength of 0.97 Å on ID29 at the European Synchrotron Radiation 
Facility (ESRF, Grenoble, France). Data were processed with the program XDS73 and the crystals belong to space 
group C121 (Table 1).
The structure was solved by the SAD method employing the data set collected at the peak wavelength 
(0.9791 Å). The phases were improved and initial model building was performed with the Phenix program suite74. 
Further model building was completed manually with Coot75 and the model was refined with REFMAC76 to 
an Rfactor of 18.7% and Rfree of 21.9%. The model contains residues 2 to 155 and 100% of the residues are within 
the most favored and allowed regions of a Ramachandran plot77. Molecular graphics figures were generated 
Figure 7. Membrane binding of the N-terminal domain of M1-C (M1C-NTD). Confocal images at the 
equator of TBE-GUVs after incubation with the M1C-NTD. The red signal corresponds to bodipy-ceramide 
lipids incorporated to the GUV membrane and the green signal to Alexa-488 M1-C. No tubulation was 
observed. The protein concentration was 2.8 μ M. Scale bars: 10 μ m.
www.nature.com/scientificreports/
1 1Scientific RepoRts | 7:40801 | DOI: 10.1038/srep40801
with PyMOL (W. Delano; http://www.pymol.org). Coordinates and structure factors have been deposited in the 
Protein Data Bank with accession ID 5M1M.
SAXS analysis. SAXS experiments were performed at the BM29 BioSAXS beamline at the ESRF (Grenoble, 
France). The proteins were purified by size-exclusion chromatography before SAXS measurements. M1-C and 
M1-A were analyzed at low pH conditions (10 mM MES pH5.7, 100 mM NaCl). The buffer of the size-exclusion 
chromatography step was used as reference for background subtraction for the SAXS measurement. For each 
sample, four different concentrations ranging between 0.8 and 4.4 mg/ml were measured. Protein solution (60 μl) 
for each sample (and buffer) was exposed to X-rays and scattering data were collected. Ten individual frames of 
30 s were collected for every exposure using a Pilatus 1 M detector (Dectris). Individual frames were processed 
automatically and independently using the software BsxCUBE, yielding individual radially averaged curves of 
normalized intensity versus scattering angle s = (4π SINθ )/λ . Frames were combined, excluding any data points 
affected by aggregation induced by radiation damage, to give the average scattering curve for each measurement 
(measured before and after every sample and background subtracted). SAXS data were processed and analysis 
steps were performed using the ATSAS package78,79. The final merged scattering data were further evaluated using 
PRIMUS. At low angle, the isotropic scattering data can be expressed as the Guinier approximation, Iexp(s) = I(0) 
exp(− s2Rg2/3). The isotropic scattering intensity I(q) was transformed to the distance distribution function P(r) 
using the program GNOM, which was also used to calculate the particle maximum dimensions Dmax. The opti-
mum value of Dmax was found when the Rg obtained from the P(r) plot was equal to that obtained from the 
Guinier analysis. For ab initio modeling of the SAXS data, 20 sets of independent models were calculated using 
Dammin80 and then averaged and aligned using DAMAVER81.
Protein labeling. M1-C containing an extra C-terminal cystein was labeled with Alexa Fluor 488 C5 
maleimide (Invitrogen). The dye was diluted to 1 mM in DMSO. M1-C in 20 mM HEPES, 300 mM NaCl, pH 7,5 
at 0.5 mg/ml was incubated for 15 min in fresh TCEP (tris(2-carboxyethyl)phosphine) (40 ug/ml) followed by 
addition of the dye with a 1:1 protein:label ratio. After incubation overnight at 4 °C, free label was removed by size 
exclusion chromatography.
Giant unilamellar vesicle preparation. Two different lipid compositions were used to form the GUVs. 
One natural composition (referred herein as TBE-GUVs) consisting of (in molar %): 94% BTE, 5% PI(4,5)P2 
and 1% BODIPY® Texas Red ceramide. The other composition consisted of (in molar %): 33.2% DOPC, 33.2% 
DOPE, 33.2% DOPS and 0.5% BODIPY® Texas Red Ceramide (DOPS-GUVs). For control experiments, vesicles 
consisting of 99.5% DOPC and 0.5% BODIPY® Texas Red Ceramide (DOPC-GUV) (in molar %) was used. For 
the lipid colocalization experiments the concentration of BODIPY-Texas Red Ceramide was lowered to 0.15% 
(in molar %) or exchanged for the negatively charged lipid BODIPY® TMR PI(4,5)P2 at 0.1%.
The TBE-GUVs were obtained by electroformation on platinum wires. The platinum wires, 0.5 mm in diam-
eter (Goodfellow SARL, France), were mounted in an in-house made teflon chamber, which places the wires 
3 mm apart. The lipids were dissolved in chloroform to a concentration of 3 mg/ml, premixed and deposited on 
the wires in small droplets to a total volume of 3 μ l. The chamber and wires were then dried in vacuum for 30 min 
before being rehydrated in buffer containing 10 mM TRIS, 50 mM NaCl and 100 mM Sucrose (pH 7.5). The cham-
ber was sealed with sigillum wax (Vitrex, Denmark), high vacuum grease (Dow Corning, USA) and two glass 
cover slips (Menzel-Gläser, Germany). A function generator was then connected to the wires with a sinusoidal 
wave of 500 Hz and 280 mV RMS-voltage.
The GUVS were left to grow overnight (12–15 hours) at 4 °C and extracted through gentle pipetting directly 
above the wires.
The control experiments with DOPC-GUVs, and some of DOPS-GUVs experiments were performed after 
growing the vesicles by electroformation from indium tin oxide (ITO). coated glass slides (Präzisionsglas & Optik 
GmbH, Germany). In this case, a lipid film was deposited by adding 10 μ l of a lipid mix (0.5 mg/ml) on the two 
slides and dried in high vacuum for 1 hour. To get a more homogeneous incorporation of the charged lipids 
into the vesicles, the lipid mix and ITO-plates were heated to 60 °C for 5 min prior and after spreading of the 
lipid films as described elsewhere59. The slides were then mounted together, 1 mm apart and a sucrose solution 
(100 mM) was added to a chamber made with sigillum wax (Vitrex, Denmark) around the dried lipid films. A 
sinus wave with RMS-voltage of 1 V and frequency of 10 Hz was then applied over the ITO -plates for 30–45 min 
(DOPS-GUV) or 60–120 min (DOPC-GUV). The vesicles were then extracted by pipetting directly from the 
chamber. The tubulation or protein binding behavior was found to be the same, regardless of the electroformation 
method chosen.
Protein binding experiments. Protein binding experiments were performed using observation chambers 
produced in house from coverslips and coated with β -casein by incubation for 15–30 min (5 mg/ml, 10 mM TRIS, 
100 mM NaCl at pH 7.5) followed by rinsing with experiment buffer. Protein binding experiments were carried out in 
TRIS buffer (10 mM Tris, 50 mM NaCl at pH 7.5 and adjusted to the same osmolarity as the vesicle growth medium 
by adding glucose). The vesicles were injected into the observation chamber filled with protein solution at required 
concentration leading in a 4:1 protein:GUV volume ratio and incubated for at least 30 min before observation.
Microscopy. The vesicles were imaged using a spinning disk system set up on inverted Nikon eclipse 
Ti-E at The BioImaging Cell and Tissue Core Facility of the Institut Curie (PICT-IBiSA), member of the 
France-BioImaging national research infrastructure. The images were recorded on a CoolSNAP HQ2 camera. 
Some images were also recorded with an EMCCD iXon 897 Andor camera. All data for quantification based 
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on fluorescence intensity were taken on the same microscope with the same camera (CoolSNAP HQ2 camera), 
using the same settings. The only parameter that was changed between samples was the exposure time. This was 
necessary to allow imaging of both low intensity samples and high intensity samples with the same laser power 
without saturating the detector.
Data analysis. The data analysis was done with ImageJ and Matlab. To calculate the mean binding intensity 
of the vesicles at the equatorial plane, the OvalProfile plugin for ImageJ was used. The background signal was 
measured close to the vesicle and subtracted from the mean intensity. The same microscope and laser settings 
were used for all images except for the exposure time, which was normalized and scaled to the same value accord-
ing to established methods using the dark pixel intensity of the camera82. To better visualize the z-stacks, the 
standard deviation z-projection from the top or bottom plane of the vesicle to the vesicle equator plane was used. 
For the tubulation quantification, the number of vesicles that displayed tubulation and the number of tubules at 
the equatorial plane of the vesicle were counted manually.
A rough estimate of the tubule diameter was obtained using a model-independent method: it makes use of the 
fact that the fact that the mean fluorescence intensity of a tubule normalized with the mean fluorescence intensity 
of the GUV is proportional to the tubule radius, as described in detail in59. The fluorescent intensity of the tubules 
was measured manually by drawing a line along the tubules and taking the mean intensity along that line, fol-
lowed by subtraction of the background signal. The tubule intensity was then normalized with the GUV intensity 
(measured as described above) and multiplied with a proportionality constant of 200 nm59.
References
1. McMahon, H. T. & Gallop, J. L. Membrane curvature and mechanisms of dynamic cell membrane remodelling. Nature 438, 
590–596, doi: 10.1038/nature04396 (2005).
2. Rossman, J. S. & Lamb, R. A. Influenza virus assembly and budding. Virology 411, 229–236, doi: 10.1016/j.virol.2010.12.003 (2011).
3. Beigel, J. H. Influenza. Crit Care Med 36, 2660–2666, doi: 10.1097/CCM.0b013e318180b039 (2008).
4. Matsuzaki, Y. et al. Clinical features of influenza C virus infection in children. J Infect Dis 193, 1229–1235, doi: 10.1086/502973 (2006).
5. Homma, M., Ohyama, S. & Katagiri, S. Age distribution of the antibody to type C influenza virus. Microbiol Immunol 26, 639–642 (1982).
6. Nayak, D. P., Hui, E. K. W. & Barman, S. Assembly and budding of influenza virus. Virus Res 106, 147–165, doi: 10.1016/j.
virusres.2004.08.012 (2004).
7. Seladi-Schulman, J., Steel, J. & Lowen, A. C. Spherical influenza viruses have a fitness advantage in embryonated eggs, while 
filament-producing strains are selected in vivo. J Virol 87, 13343–13353, doi: 10.1128/JVI.02004-13 (2013).
8. Vijayakrishnan, S. et al. Cryotomography of budding influenza A virus reveals filaments with diverse morphologies that mostly do 
not bear a genome at their distal end. PLoS Pathog 9, e1003413, doi: 10.1371/journal.ppat.1003413 (2013).
9. Rossman, J. S., Jing, X., Leser, G. P. & Lamb, R. A. Influenza virus M2 protein mediates ESCRT-independent membrane scission. Cell 
142, 902–913, doi: 10.1016/j.cell.2010.08.029 (2010).
10. Chen, B. J. & Lamb, R. A. Mechanisms for enveloped virus budding: can some viruses do without an ESCRT? Virology 372, 221–232, 
doi: 10.1016/j.virol.2007.11.008 (2008).
11. Weissenhorn, W., Poudevigne, E., Effantin, G. & Bassereau, P. How to get out: ssRNA enveloped viruses and membrane fission. Curr 
Opin Virol 3, 159–167, doi: 10.1016/j.coviro.2013.03.011 (2013).
12. Radzimanowski, J., Effantin, G. & Weissenhorn, W. Conformational plasticity of the Ebola virus matrix protein. Protein Sci 23, 
1519–1527, doi: 10.1002/pro.2541 (2014).
13. Liljeroos, L., Krzyzaniak, M. A., Helenius, A. & Butcher, S. J. Architecture of respiratory syncytial virus revealed by electron 
cryotomography. P Natl Acad Sci USA 110, 11133–11138, doi: 10.1073/pnas.1309070110 (2013).
14. Welsch, S., Muller, B. & Krausslich, H. G. More than one door - Budding of enveloped viruses through cellular membranes. FEBS 
Lett 581, 2089–2097, doi: 10.1016/j.febslet.2007.03.060 (2007).
15. Enami, M. & Enami, K. Influenza virus hemagglutinin and neuraminidase glycoproteins stimulate the membrane association of the 
matrix protein. J Virol 70, 6653–6657 (1996).
16. Ali, A., Avalos, R. T., Ponimaskin, E. & Nayak, D. P. Influenza virus assembly: effect of influenza virus glycoproteins on the 
membrane association of M1 protein. J Virol 74, 8709–8719 (2000).
17. Wang, D. et al. The lack of an inherent membrane targeting signal is responsible for the failure of the matrix (M1) protein of 
influenza A virus to bud into virus-like particles. J Virol 84, 4673–4681, doi: 10.1128/JVI.02306-09 (2010).
18. Gomez-Puertas, P., Albo, C., Perez-Pastrana, E., Vivo, A. & Portela, A. Influenza virus matrix protein is the major driving force in 
virus budding. J Virol 74, 11538–11547 (2000).
19. Latham, T. & Galarza, J. M. Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of 
only four structural proteins. J Virol 75, 6154–6165, doi: 10.1128/JVI.75.13.6154-6165.2001 (2001).
20. Chen, B. J., Leser, G. P., Morita, E. & Lamb, R. A. Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are 
required for assembly and budding of plasmid-derived virus-like particles. J Virol 81, 7111–7123, doi: 10.1128/JVI.00361-07 (2007).
21. Chlanda, P. et al. Structural Analysis of the Roles of Influenza A Virus Membrane-Associated Proteins in Assembly and Morphology. 
J Virol 89, 8957–8966, doi: 10.1128/JVI.00592-15 (2015).
22. Burleigh, L. M., Calder, L. J., Skehel, J. J. & Steinhauer, D. A. Influenza a viruses with mutations in the M1 helix six domain display a 
wide variety of morphological phenotypes. J Virol 79, 1262–1270, doi: 10.1128/Jvi.79.2.12162-1270.2005 (2005).
23. Muraki, Y. et al. A mutation on influenza C virus M1 protein affects virion morphology by altering the membrane affinity of the 
protein. J Virol 81, 8766–8773, doi: 10.1128/Jvi.00075-07 (2007).
24. Elleman, C. J. & Barclay, W. S. The M1 matrix protein controls the filamentous phenotype of influenza A virus. Virology 321, 
144–153, doi: 10.1016/j.virol.2003.12.009 (2004).
25. Muraki, Y. et al. Identification of an amino acid residue on influenza C virus M1 protein responsible for formation of the cord-like 
structures of the virus. J Gen Virol 85, 1885–1893, doi: 10.1099/vir.0.79937-0 (2004).
26. Nishimura, H. et al. Characterization of the Cord-Like Structures Emerging from the Surface of Influenza C Virus-Infected Cells. 
Virology 179, 179–188, doi: 10.1016/0042-6822(90)90287-2 (1990).
27. Nishimura, H. et al. The Ability of Influenza-C Virus to Generate Cord-Like Structures Is Influenced by the Gene Coding for 
M-Protein. Virology 200, 140–147, doi: 10.1006/viro.1994.1172 (1994).
28. Harris, A., Forouhar, F., Qiu, S., Sha, B. & Luo, M. The crystal structure of the influenza matrix protein M1 at neutral pH: M1-M1 
protein interfaces can rotate in the oligomeric structures of M1. Virology 289, 34–44, doi: 10.1006/viro.2001.1119 (2001).
29. Sha, B. & Luo, M. Structure of a bifunctional membrane-RNA binding protein, influenza virus matrix protein M1. Nat Struct Biol 4, 
239–244 (1997).
30. Arzt, S. et al. Combined results from solution studies on intact influenza virus M1 protein and from a new crystal form of its 
N-terminal domain show that M1 is an elongated monomer. Virology 279, 439–446, doi: 10.1006/viro.2000.0727 (2001).
www.nature.com/scientificreports/
13Scientific RepoRts | 7:40801 | DOI: 10.1038/srep40801
31. Safo, M. K. et al. Crystal structures of influenza A virus matrix protein M1: variations on a theme. PloS one 9, e109510, doi: 10.1371/
journal.pone.0109510 (2014).
32. Baudin, F., Petit, I., Weissenhorn, W. & Ruigrok, R. W. In vitro dissection of the membrane and RNP binding activities of influenza 
virus M1 protein. Virology 281, 102–108, doi: 10.1006/viro.2000.0804 (2001).
33. Das, S. C. et al. The Highly Conserved Arginine Residues at Positions 76 through 78 of Influenza A Virus Matrix Protein M1 Play an 
Important Role in Viral Replication by Affecting the Intracellular Localization of M1. J Virol 86, 1522–1530, doi: 10.1128/Jvi.06230-
11 (2012).
34. Kerviel, A. et al. Involvement of an Arginine Triplet in M1 Matrix Protein Interaction with Membranes and in M1 Recruitment into 
Virus-Like Particles of the Influenza A(H1N1)pdm09 Virus. PloS one 11, e0165421, doi: 10.1371/journal.pone.0165421 (2016).
35. Thaa, B., Herrmann, A. & Veit, M. The polybasic region is not essential for membrane binding of the matrix protein M1 of influenza 
virus. Virology 383, 150–155, doi: 10.1016/j.virol.2008.10.001 (2009).
36. Okada, A., Miura, T. & Takeuchi, H. Zinc- and pH-dependent conformational transition in a putative interdomain linker region of 
the influenza virus matrix protein M1. Biochemistry-Us 42, 1978–1984, doi: 10.1021/bi027176t (2003).
37. Zhang, N. et al. Advancements in the development of subunit influenza vaccines. Microbes Infect 17, 123–134, doi: 10.1016/j.
micinf.2014.12.006 (2015).
38. Zhang, K. et al. Two polar residues within C-terminal domain of M1 are critical for the formation of influenza A Virions. Cell 
Microbiol, doi: 10.1111/cmi.12457 (2015).
39. Arzt, S. et al. Combined results from solution studies on intact influenza virus M1 protein and from a new crystal form of its 
N-terminal domain show that M1 is an elongated monomer. Virology 279, 439–446, doi: 10.1006/viro.2000.0727 (2001).
40. Shtykova, E. V. et al. Structural analysis of influenza A virus matrix protein M1 and its self-assemblies at low pH. PloS one 8, e82431, 
doi: 10.1371/journal.pone.0082431 (2013).
41. Hilsch, M. et al. Influenza A matrix protein M1 multimerizes upon binding to lipid membranes. Biophys J 107, 912–923, doi: 
10.1016/j.bpj.2014.06.042 (2014).
42. Calder, L. J., Wasilewski, S., Berriman, J. A. & Rosenthal, P. B. Structural organization of a filamentous influenza A virus. Proc Natl 
Acad Sci USA 107, 10685–10690, doi: 10.1073/pnas.1002123107 (2010).
43. Li, S. et al. pH-Controlled two-step uncoating of influenza virus. Biophys J 106, 1447–1456, doi: 10.1016/j.bpj.2014.02.018 (2014).
44. Fontana, J., Cardone, G., Heymann, J. B., Winkler, D. C. & Steven, A. C. Structural changes in Influenza virus at low pH characterized 
by cryo-electron tomography. J Virol 86, 2919–2929, doi: 10.1128/JVI.06698-11 (2012).
45. Fontana, J. & Steven, A. C. At low pH, influenza virus matrix protein M1 undergoes a conformational change prior to dissociating 
from the membrane. J Virol 87, 5621–5628, doi: 10.1128/JVI.00276-13 (2013).
46. Lagny, T. J. & Bassereau, P. Bioinspired membrane-based systems for a physical approach of cell organization and dynamics: 
usefulness and limitations. Interface Focus 5, doi: Artn 20150038 10.1098/Rsfs.2015.0038 (2015).
47. Chan, Y. H. M. & Boxer, S. G. Model membrane systems and their applications. Curr Opin Chem Biol 11, 581–587, doi: 10.1016/j.
cbpa.2007.09.020 (2007).
48. Vogel, S. K. & Schwille, P. Minimal systems to study membrane-cytoskeleton interactions. Curr Opin Biotech 23, 758–765, doi: 
10.1016/j.copbio.2012.03.012 (2012).
49. Arumugam, S., Chwastek, G. & Schwille, P. Protein-membrane interactions: the virtue of minimal systems in systems biology. Wires 
Syst Biol Med 3, 269–280, doi: 10.1002/wsbm.119 (2011).
50. Walde, P., Cosentino, K., Engel, H. & Stano, P. Giant Vesicles: Preparations and Applications. Chembiochem 11, 848–865, doi: 
10.1002/cbic.201000010 (2010).
51. Aranda-Espinoza, H. et al. Electrostatic repulsion of positively charged vesicles and negatively charged objects. Science 285, 
394–397, doi: 10.1126/science.285.5426.394 (1999).
52. Tsafrir, I., Caspi, Y., Guedeau-Boudeville, M. A., Arzi, T. & Stavans, J. Budding and tubulation in highly oblate vesicles by anchored 
amphiphilic molecules. Phys Rev Lett 91, doi: Artn 138102 10.1103/Physrevlett.91.138102 (2003).
53. Denisov, G., Wanaski, S., Luan, P., Glaser, M. & McLaughlin, S. Binding of basic peptides to membranes produces lateral domains 
enriched in the acidic lipids phosphatidylserine and phosphatidylinositol 4,5-bisphosphate: An electrostatic model and experimental 
results. Biophys J 74, 731–744 (1998).
54. Solon, J., Gareil, O., Bassereau, P. & Gaudin, Y. Membrane deformations induced by the matrix protein of vesicular stomatitis virus 
in a minimal system. J Gen Virol 86, 3357–3363, doi: 10.1099/vir.0.81129-0 (2005).
55. Romer, W. et al. Shiga toxin induces tubular membrane invaginations for its uptake into cells. Nature 450, 670–U673, doi: 10.1038/
nature05996 (2007).
56. Shnyrova, A. V. et al. Vesicle formation by self-assembly of membrane-bound matrix proteins into a fluidlike budding domain. J Cell 
Biol 179, 627–633, doi: 10.1083/jcb.200705062 (2007).
57. Arzt, S., Petit, I., Burmeister, W. P., Ruigrok, R. W. & Baudin, F. Structure of a knockout mutant of influenza virus M1 protein that 
has altered activities in membrane binding, oligomerisation and binding to NEP (NS2). Virus Res 99, 115–119 (2004).
58. Ruigrok, R. W. H. et al. Membrane interaction of influenza virus M1 protein. Virology 267, 289–298, doi: 10.1006/viro.1999.0134 
(2000).
59. Sorre, B. et al. Nature of curvature coupling of amphiphysin with membranes depends on its bound density. P Natl Acad Sci USA 
109, 173–178, doi: 10.1073/pnas.1103594108 (2012).
60. Costes, S. V. et al. Automatic and quantitative measurement of protein-protein colocalization in live cells. Biophys J 86, 3993–4003, 
doi: 10.1529/biophysj.103.038422 (2004).
61. Burleigh, L. M., Calder, L. J., Skehel, J. J. & Steinhauer, D. A. Influenza a viruses with mutations in the m1 helix six domain display a 
wide variety of morphological phenotypes. J Virol 79, 1262–1270, doi: 10.1128/JVI.79.2.1262-1270.2005 (2005).
62. Zhang, K. et al. Dissection of influenza A virus M1 protein: pH-dependent oligomerization of N-terminal domain and dimerization 
of C-terminal domain. PloS one 7, e37786, doi: 10.1371/journal.pone.0037786 (2012).
63. Soni, S. P. & Stahelin, R. V. The Ebola Virus Matrix Protein VP40 Selectively Induces Vesiculation from Phosphatidylserine-enriched 
Membranes. J Biol Chem 289, 33590–33597, doi: 10.1074/jbc.M114.586396 (2014).
64. Simunovic, M., Srivastava, A. & Voth, G. A. Linear aggregation of proteins on the membrane as a prelude to membrane remodeling. 
P Natl Acad Sci USA 110, 20396–20401, doi: 10.1073/pnas.1309819110 (2013).
65. Simunovic, M. & Voth, G. A. Membrane tension controls the assembly of curvature-generating proteins. Nature communications 6, 
doi: Artn 7219 10.1038/Ncomms8219 (2015).
66. Noguchi, H. Membrane tubule formation by banana-shaped proteins with or without transient network structure. Sci Rep-Uk 6, doi: 
Artn 20935 10.1038/Srep20935 (2016).
67. Simunovic, M. et al. How curvature-generating proteins build scaffolds on membrane nanotubes. P Natl Acad Sci USA 113, 
11226–11231, doi: 10.1073/pnas.1606943113 (2016).
68. Shi, Z. & Baumgart, T. Membrane tension and peripheral protein density mediate membrane shape transitions. Nature 
communications 6, doi: Artn 5974 10.1038/Ncomms6974 (2015).
69. Nayak, D. P., Balogun, R. A., Yamada, H., Zhou, Z. H. & Barman, S. Influenza virus morphogenesis and budding. Virus Res 143, 
147–161, doi: 10.1016/j.virusres.2009.05.010 (2009).
70. Baumgart, T., Hess, S. T. & Webb, W. W. Imaging coexisting fluid domains in biomembrane models coupling curvature and line 
tension. Nature 425, 821–824, doi: 10.1038/nature02013 (2003).
www.nature.com/scientificreports/
1 4Scientific RepoRts | 7:40801 | DOI: 10.1038/srep40801
71. Roux, A. et al. Role of curvature and phase transition in lipid sorting and fission of membrane tubules. Embo J 24, 1537–1545, doi: 
10.1038/sj.emboj.7600631 (2005).
72. Vahey, M. D. & Fletcher, D. A. In Vitro Reconstitution of Membrane Budding by Influenza A Virus Matrix Protein 1. Biophys J 106, 
62a–62a (2014).
73. Kabsch, W. Xds. Acta Crystallogr D Biol Crystallogr 66, 125–132 (2010).
74. Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol 
Crystallogr 66, 213–221, doi: 10.1107/S0907444909052925 (2010).
75. Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66, 
486–501 (2010).
76. Murshudov, G. N., Vagin, A. A. & Dodson, E. J. Refinement of Macromolecular Structures by the Maximum-Likelihood Method. 
Acta Crystallographica Section D 53, 240–255 (1997).
77. Winn, M. D. et al. Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr 67, 235–242, doi: 
10.1107/S0907444910045749 (2011).
78. Konarev, P. V., Petoukhov, M. V., Volkov, V. V. & Svergun, D. I. ATSAS 2.1, a Program Package for Small-Angle Scattering Data 
Analysis. Journal of Applied Crystallography 39, 277–286 (2006).
79. Putnam, C. D., Hammel, M., Hura, G. L. & Tainer, J. A. X-ray solution scattering (SAXS) combined with crystallography and computation: 
defining accurate macromolecular structures, conformations and assemblies in solution. Q Rev Biophys 40, 191–285 (2007).
80. Svergun, D. I. Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing. 
Biophys. J. 76, 2879–2886 (1999).
81. Konarev, P. V., Volkov, V. V., Sokolova, A. V., Koch, M. H. J. & Svergun, D. I. PRIMUS: a Windows PC-based system for small-angle 
scattering data analysis. J. appl. Cryst. 36, 1277–1282 (2003).
82. Pang, Z., Laplante, N. E. & Filkins, R. J. Dark pixel intensity determination and its applications in normalizing different exposure 
time and autofluorescence removal. Journal of microscopy 246, 1–10, doi: 10.1111/j.1365-2818.2011.03581.x (2012).
Acknowledgements
This work was supported by the Marie Curie actions (FP7-PEOPLE-2012-IEF, project FLUMABUD) (MB), the 
Swedish Research Council (621-2012-5024) (MB), the ANR (ANR-10-BLAN-1329) (WW), the Labex GRAL 
(ANR-10-LABX-49-01) and the Institut Universitaire de France (WW). We acknowledge the platforms of the 
Grenoble Instruct center (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) supported by the French Infrastructure for 
Integrated Structural Biology Initiative FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01) within 
the Grenoble Partnership for Structural Biology (PSB). We also thank the ESRF-EMBL Joint Structural Biology 
Group for access and support at the ESRF beam lines and J. Marquez (EMBL) from the crystallization platform. 
We further thank François Waharte at the microscopy center PICT-IBiSA (Institut Curie, Paris), member of 
the France-BioImaging national research infrastructure (ANR-10-INSB-04) for assistance with fluorescence 
microscopy. The P.B. group belongs to the CNRS consortium CellTiss, to the Labex CelTisPhyBio (ANR-11-
LABX0038), and to Paris Sciences et Lettres (ANR-10-IDEX-0001-02). Mijo Simunovic and Feng Tsing Tsai 
(Institut Curie) are acknowledged for general discussions and help with setting up the experiments. Nicola De 
Franceschi is acknowledged for help with data evaluation.
Author Contributions
W.W., P.B. and M.B. designed the project. Protein purification and structural characterization was performed 
by J.R. Experiments on GUVs were performed by D.S. and M.B. with help of S.M. Electron microscopy 
was performed by G.E. Colocalization analysis was performed by D.M., D.S., M.B., P.B. and W.W. wrote the 
manuscript. The manuscript was read and approved by all co-authors.
Additional Information
Supplementary information accompanies this paper at http://www.nature.com/srep
Competing financial interests: The authors declare no competing financial interests.
How to cite this article: Saletti, D. et al. The Matrix protein M1 from influenza C virus induces tubular 
membrane invaginations in an in vitro cell membrane model. Sci. Rep. 7, 40801; doi: 10.1038/srep40801 (2017).
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
This work is licensed under a Creative Commons Attribution 4.0 International License. The images 
or other third party material in this article are included in the article’s Creative Commons license, 
unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, 
users will need to obtain permission from the license holder to reproduce the material. To view a copy of this 
license, visit http://creativecommons.org/licenses/by/4.0/
 
© The Author(s) 2017
